1. Abramson, E., Arky, R.A.: Treatment of obese diabetics, a comparative study of placebo, sulfonylurea and phenformin. Metabolism16, 204?212 (1967).
2. Anderson, J., Coulsen, R., Grassick, B.D.M., Morris, B.A., Thomas, W.D., Tomlinson, R.W.S., Woodroffe, F.: Clinical and metabolic study in diabetic patients treated with glibenclamide. Brit. med. J.1971 II, 568?570.
3. Appels, A., Kattermann, R., Proschek, H., Hubrich, K., Frerichs, H., Söling, H.D., Creutzfeldt, W.: Untersuchungen über die Wirkung von Diät, Tolbutamid und Buformin, sowie deren Kombination auf Körpergewicht und verschiedene Stoffwechselgrößen bei Diabetikern. I. Körpergewicht, Kohlenhydratstoffwechsel und immunologisch reagierendes Insulin. Diabetologia4, 210?220 (1968).
4. Bagdade, J.D., Bierman, E.L., Porte, D.: The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J. clin. Invest.46, 1549?1557 (1967).
5. Belknap, B.H., Bagdade, J.D., Amaral, J.A.P., Bierman, E.L.: Plasma lipids and mild glucose intolerance. II. A double blind study of the effect of tolbutamide and placebo in mild adult diabetic outpatients. In: Butterfield, W.J.H., van Westering, W. (ed.) Tolbutamide ... after ten years, p. 171. Amsterdam Excerpta Med. Found. 1967.